Viewing nowBugang Rosuvastatin Calcium Tablet 20mg
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Bugang Pharm Co., Ltd.

MFDS item code 201501709 · Approved 2015.03.31 · Insurance code 642203670
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is used as an adjunct to diet for patients with primary hypercholesterolemia and mixed dyslipidemia who have difficulty controlling cholesterol levels with diet and exercise. Additionally, patients with homozygous familial hypercholesterolemia may use this medication alongside dietary therapy or other lipid-lowering treatments. This medication helps lower total cholesterol and LDL cholesterol levels to target levels, thereby slowing the progression of atherosclerosis. It is also utilized as an adjunct to therapy for patients with primary dysbetalipoproteinemia. Furthermore, in middle-aged individuals with elevated high-sensitivity C-reactive protein levels and additional cardiovascular risk factors, this medication is used to reduce the risk of stroke, myocardial infarction, and arterial revascularization. Therefore, this medicine is effectively used for various types of hypercholesterolemia and cardiovascular disease risk reduction.
1. Primary hypercholesterolemia (type IIa, excluding heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer based on LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dosage adjustment is necessary. 3. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
This medication may not be used in certain patients. For example, it should not be administered to patients with allergies to this medication, patients with severe liver dysfunction, patients with muscle disorders, patients taking certain medications concurrently, and patients with severely impaired kidney function. Moreover, women who are pregnant, nursing, or may become pregnant should consult a doctor and use appropriate contraceptive methods before taking this medication. This medication can affect muscles, leading to muscle pain or damage, so any muscle-related symptoms should be reported to healthcare professionals immediately. Since liver function may be affected, liver function tests should be conducted regularly while on this medication, and it should be discontinued immediately if symptoms of liver damage occur. Patients who consume large amounts of alcohol or have a history of liver disease should use this medication with particular caution and should have liver function tests as per a doctor's instructions. Additionally, this medication may interact with certain drugs, so if other medications are being taken, healthcare professionals should be informed. In particular, caution is needed when taken with drugs that have a high risk of muscle toxicity, as the risk of muscle damage may increase. Rarely, this medication can cause severe allergic reactions on the skin; if symptoms such as rash, itching, or difficulty breathing occur, the medication should be stopped immediately and medical attention sought. Pregnant or nursing women should not take this medication, and women planning pregnancy should consult a doctor before starting it. In case of overdose, since there is no specific antidote, immediate medical attention should be sought, and liver and muscle function tests should be performed. Caution is advised while driving or operating machinery, as dizziness may occur. This medication may have higher blood concentrations in Asian individuals; thus, dosage adjustments may be necessary. When used in children and adolescents, it should be used under a doctor's guidance, as it may affect growth and development.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, anorexia, abdominal distention, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is also advisable to avoid storing it in excessively hot or cold places, ideally keeping it at room temperature between 1°C and 30°C.
Pink round film-coated tablet
28 tablets (14 tablets/PTP x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Bugang Pharm Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.